- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted drug delivery strategies for precision medicines
Authors
Keywords
-
Journal
Nature Reviews Materials
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-03
DOI
10.1038/s41578-020-00269-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
- (2020) Tuo Wei et al. Nature Communications
- Chemical structure modifications and nano-technology applications for improving ADME-Tox properties, a review
- (2019) Faten Farouk et al. ARCHIV DER PHARMAZIE
- Development challenges and opportunities in aerosol drug delivery systems in non-invasive ventilation in adults
- (2019) Gregory Reychler et al. Expert Opinion on Drug Delivery
- Combination of sunitinib and PD-L1 blockade enhances anticancer efficacy of TLR7/8 agonist-based nanovaccine
- (2019) Hyunjoon Kim et al. MOLECULAR PHARMACEUTICS
- Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study
- (2019) Todd Mainprize et al. Scientific Reports
- Targeting the mTOR Signaling Pathway Utilizing Nanoparticles: A Critical Overview
- (2019) Mariia Lunova et al. Cancers
- Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study
- (2019) Jakob Nikolas Kather et al. PLOS MEDICINE
- Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors
- (2019) Ariella B. Hanker et al. Cancer Discovery
- Targeting Alterations in the RAF–MEK Pathway
- (2019) Rona Yaeger et al. Cancer Discovery
- Properties of FDA-approved small molecule protein kinase inhibitors
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness
- (2019) Fei Peng et al. Nature Nanotechnology
- Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
- (2019) Qian Chen et al. ADVANCED MATERIALS
- A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
- (2019) Gabriel Mak et al. BRITISH JOURNAL OF CANCER
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models
- (2019) Mandana T. Manzari et al. Science Advances
- Sorafenib-Loaded Ligand-Functionalized Polymer-Lipid Hybrid Nanoparticles for Enhanced Therapeutic Effect Against Liver Cancer
- (2019) Shijing Tang et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy
- (2018) Ling-xiao Zhang et al. BIOMATERIALS
- Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy
- (2018) Shuo Fang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma
- (2018) Dalia M. Kabary et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Novel everolimus-loaded nanocarriers for topical treatment of murine experimental autoimmune uveoretinitis (EAU)
- (2018) Maren Kasper et al. EXPERIMENTAL EYE RESEARCH
- Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
- (2018) Nadda Muhamad et al. International Journal of Nanomedicine
- Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
- (2018) Samaresh Sau et al. JOURNAL OF CONTROLLED RELEASE
- Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
- (2018) Rhian M. Touyz et al. Journal of the American Society of Hypertension
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer
- (2018) Chang Liu et al. MOLECULAR PHARMACEUTICS
- Quantitative self-assembly prediction yields targeted nanomedicines
- (2018) Yosi Shamay et al. NATURE MATERIALS
- A facile approach to enhance antigen response for personalized cancer vaccination
- (2018) Aileen Weiwei Li et al. NATURE MATERIALS
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- ERK Inhibition: A New Front in the War against MAPK Pathway–Driven Cancers?
- (2018) Inna Smalley et al. Cancer Discovery
- Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
- (2018) Wendu Duan et al. Drug Design Development and Therapy
- Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells
- (2018) Vojtech Novohradsky et al. Oncotarget
- Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer
- (2018) Siva Sai Krishna Dasa et al. Theranostics
- Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy
- (2018) Barbara Cortese et al. Pharmaceutics
- Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy
- (2018) Kuangda Lu et al. Nature Biomedical Engineering
- Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
- (2018) Hiroki Sato et al. CANCER SCIENCE
- Tumor drug penetration measurements could be the neglected piece of the personalized cancer treatment puzzle
- (2018) Imke H. Bartelink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
- (2018) Francis Man et al. MOLECULAR IMAGING AND BIOLOGY
- Immunomodulating Nanomedicine for Cancer Therapy
- (2018) Zhigang Liu et al. NANO LETTERS
- Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index
- (2018) Sebastian Kallus et al. Nanomedicine-Nanotechnology Biology and Medicine
- New features in MEK retinopathy
- (2018) Pallavi Tyagi et al. BMC Ophthalmology
- Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 (BRCA2) Mutation
- (2018) Chong Du et al. ACS Nano
- Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy
- (2018) You Ke et al. International Journal of Nanomedicine
- PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
- (2018) Hamideh Parhiz et al. JOURNAL OF CONTROLLED RELEASE
- Development of Ultrasound-Triggered and Magnetic-Targeted Nanobubble System for Dual-Drug Delivery
- (2018) Şenay Hamarat Şanlıer et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution
- (2018) Cory D. Sago et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
- (2018) Quanyin Hu et al. Nature Biomedical Engineering
- Mesoporous silica templated-albumin nanoparticles with high doxorubicin payload for drug delivery assessed with a 3-D tumor cell model
- (2018) Mathilde Ménard et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Selective Nanoparticle Targeting of the Renal TubulesNovelty and Significance
- (2017) Ryan M. Williams et al. HYPERTENSION
- Gold nanoparticles reduce high glucose-induced oxidative-nitrosative stress regulated inflammation and apoptosis via tuberin-mTOR/NF-κB pathways in macrophages
- (2017) Huma Rizwan et al. International Journal of Nanomedicine
- Targeted drug delivery of Sunitinib Malate to tumor blood vessels by cRGD-chiotosan-gold nanoparticles
- (2017) Mohaddeseh Mahmoudi Saber et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension
- (2017) Victor Segura-Ibarra et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment
- (2017) Meirong Huo et al. JOURNAL OF CONTROLLED RELEASE
- Microneedle, bio-microneedle and bio-inspired microneedle: A review
- (2017) Guojun Ma et al. JOURNAL OF CONTROLLED RELEASE
- A combinatorial approach of inclusion complexation and dendrimer synthesization for effective targeting EGFR-TK
- (2017) Pravin Shende et al. Materials Science & Engineering C-Materials for Biological Applications
- Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy
- (2017) Zilan Zhou et al. MOLECULAR PHARMACEUTICS
- Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA
- (2017) Siddharth Patel et al. NANO LETTERS
- Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy
- (2017) Sung Duk Jo et al. Nano Today
- Drug development in the era of precision medicine
- (2017) Sarah A. Dugger et al. NATURE REVIEWS DRUG DISCOVERY
- PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D
- (2017) Eneda Toska et al. SCIENCE
- Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers
- (2017) Chaoyang Sun et al. Science Translational Medicine
- Computational and mechanistic studies on the effect of galactoxyloglucan: Imatinib nanoconjugate in imatinib resistant K562 cells
- (2017) Alphy Rose James et al. TUMOR BIOLOGY
- Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma
- (2017) Aviram Mizrachi et al. Nature Communications
- T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
- (2017) Daniela Schmid et al. Nature Communications
- Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
- (2017) Giles W. Robinson et al. Oncotarget
- Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma
- (2017) Inbal Hazkani et al. Theranostics
- Unusual Magnetic Resonance Imaging Findings of a Glioblastoma Arising During Treatment with Lenvatinib for Thyroid Cancer
- (2017) Nobuhiko Arai et al. World Neurosurgery
- Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies
- (2017) Azadeh Haeri et al. Artificial Cells Nanomedicine and Biotechnology
- Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo
- (2016) Tuomo Nissinen et al. ACS Applied Materials & Interfaces
- iRGD-Decorated Polymeric Nanoparticles for the Efficient Delivery of Vandetanib to Hepatocellular Carcinoma: Preparation and in Vitro and in Vivo Evaluation
- (2016) Jianguo Wang et al. ACS Applied Materials & Interfaces
- Surface Charge Controls the Suborgan Biodistributions of Gold Nanoparticles
- (2016) Sukru Gokhan Elci et al. ACS Nano
- Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
- (2016) Jason B. Miller et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pan-European inter-laboratory studies on a panel of in vitro cytotoxicity and pro-inflammation assays for nanoparticles
- (2016) Jean-Pascal Piret et al. ARCHIVES OF TOXICOLOGY
- Idelalisib in the management of lymphoma
- (2016) C. Y. Cheah et al. BLOOD
- New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation
- (2016) Matthias Waldner et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors
- (2016) Varun Goel et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Gelatin-coated Gold Nanoparticles as Carriers of FLT3 Inhibitors for Acute Myeloid Leukemia Treatment
- (2016) Sorina Suarasan et al. Chemical Biology & Drug Design
- Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
- (2016) Nazila Kamaly et al. CHEMICAL REVIEWS
- Lessons Learned: Dose Selection of Small Molecule-Targeted Oncology Drugs
- (2016) J. M. Bullock et al. CLINICAL CANCER RESEARCH
- Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience
- (2016) Han Hsi Wong et al. EUROPEAN JOURNAL OF CANCER
- Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
- (2016) Marie de Charette et al. EUROPEAN JOURNAL OF CANCER
- Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer
- (2016) David Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models
- (2016) Yosi Shamay et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy
- (2016) Yongju He et al. JOURNAL OF CONTROLLED RELEASE
- Prolonged cellular midostaurin retention suggests potential alternative dosing strategies for FLT3-ITD-positive leukemias
- (2016) D B Lipka et al. LEUKEMIA
- Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
- (2016) Chao Wang et al. NANO LETTERS
- A combinatorial strategy for treating KRAS-mutant lung cancer
- (2016) Eusebio Manchado et al. NATURE
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management
- (2016) Khurum H. Khan et al. ONCOLOGIST
- Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
- (2016) Edward A. Sykes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
- (2016) Ming Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
- (2016) Y. Shamay et al. Science Translational Medicine
- Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury
- (2016) Simone Alidori et al. Science Translational Medicine
- Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
- (2016) Susan Ashton et al. Science Translational Medicine
- Theranostic barcoded nanoparticles for personalized cancer medicine
- (2016) Zvi Yaari et al. Nature Communications
- Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
- (2016) Carlos Pérez-Medina et al. Nature Communications
- Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activity
- (2016) Chunling Dong et al. Oncotarget
- Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
- (2016) Gan Lin et al. Advanced Science
- Cancer nanomedicine: is targeting our target?
- (2016) Twan Lammers et al. Nature Reviews Materials
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Advances in Cancer Immunotherapy in Solid Tumors
- (2016) Smitha Menon et al. Cancers
- Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability
- (2016) Annika Tuomela et al. Pharmaceutics
- Cetuximab-modified mesoporous silica nano-medicine specifically targets EGFR-mutant lung cancer and overcomes drug resistance
- (2016) Yuetong Wang et al. Scientific Reports
- Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI
- (2016) Ahmed Atef Ahmed Ali et al. Scientific Reports
- Unexpected Off-Targets and Paradoxical Pathway Activation by Kinase Inhibitors
- (2015) Oliver Hantschel ACS Chemical Biology
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers
- (2015) Bindu Thapa et al. BIOMACROMOLECULES
- Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+lymphoid malignancies
- (2015) Andrew W. Roberts et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
- (2015) Frederick H. Wilson et al. CANCER CELL
- Nanoparticles in Photodynamic Therapy
- (2015) Sasidharan Swarnalatha Lucky et al. CHEMICAL REVIEWS
- Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle
- (2015) E. C. Dreaden et al. CLINICAL CANCER RESEARCH
- Taselisib (GDC-0032), a Potent -Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations
- (2015) Z. S. Zumsteg et al. CLINICAL CANCER RESEARCH
- The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model
- (2015) Mona Alibolandi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma
- (2015) Dominik Horn et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
- (2015) Justin S. LaFountaine et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomes for Treating Invasive Breast Cancer
- (2015) Ji-Feng Shi et al. Journal of Biomedical Nanotechnology
- Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection
- (2015) Xiquan Liang et al. JOURNAL OF BIOTECHNOLOGY
- Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer–drug conjugates
- (2015) Yosi Shamay et al. JOURNAL OF CONTROLLED RELEASE
- ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
- (2015) Shundong Cang et al. Journal of Hematology & Oncology
- An Aggregation Advisor for Ligand Discovery
- (2015) John J. Irwin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Management of adverse events associated with idelalisib treatment: expert panel opinion
- (2015) Steven E. Coutré et al. LEUKEMIA & LYMPHOMA
- Crizotinib-loaded polymeric nanoparticles in lung cancer chemotherapy
- (2015) Zhi-Ming Jiang et al. MEDICAL ONCOLOGY
- Tools for Early Prediction of Drug Loading in Lipid-Based Formulations
- (2015) Linda C. Alskär et al. MOLECULAR PHARMACEUTICS
- Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug–Drug Conjugate with High Drug Loading and Antitumor Efficacy
- (2015) Qin Song et al. MOLECULAR PHARMACEUTICS
- Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
- (2015) Ryan M. Williams et al. NANO LETTERS
- Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery
- (2015) Rubel Chakravarty et al. Nanomedicine
- Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
- (2015) Timea Simon et al. Nanoscale Research Letters
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
- (2015) Shiri Weinstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
- (2015) Ana Bosch et al. Science Translational Medicine
- Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma
- (2015) N. Kramkimel et al. Targeted Oncology
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- A drug-specific nanocarrier design for efficient anticancer therapy
- (2015) Changying Shi et al. Nature Communications
- An endoscope with integrated transparent bioelectronics and theranostic nanoparticles for colon cancer treatment
- (2015) Hyunjae Lee et al. Nature Communications
- Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
- (2015) Timea Simon et al. Nanoscale Research Letters
- Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
- (2015) Sarah J. Welsh et al. Therapeutic Advances in Medical Oncology
- Delivery systems for siRNA drug development in cancer therapy
- (2015) Cong-fei Xu et al. Asian Journal of Pharmaceutical Sciences
- A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
- (2015) Christian O. de Groot et al. Frontiers in Oncology
- Nanomedicines: addressing the scientific and regulatory gap
- (2014) Sally Tinkle et al. Annals of the New York Academy of Sciences
- Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials
- (2014) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
- (2014) Randall J. Platt et al. CELL
- Colloidal gold nanoparticle conjugates of gefitinib
- (2014) Anh Thu Ngoc Lam et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Zinc finger nucleases: Tailor-made for gene therapy
- (2014) S.-T. Chou et al. DRUGS OF THE FUTURE
- Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9
- (2014) Ranran Cheng et al. FEBS LETTERS
- Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
- (2014) S. Ramakrishna et al. GENOME RESEARCH
- Cancer active targeting by nanoparticles: a comprehensive review of literature
- (2014) Remon Bazak et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
- (2014) Zheng Hu et al. JOURNAL OF CLINICAL INVESTIGATION
- RAS interaction with PI3K p110α is required for tumor-induced angiogenesis
- (2014) Miguel Manuel Murillo et al. JOURNAL OF CLINICAL INVESTIGATION
- Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
- (2014) Simonetta M. Leto et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia
- (2014) L Schafranek et al. LEUKEMIA
- Triphenylalanine peptides self-assemble into nanospheres and nanorods that are different from the nanovesicles and nanotubes formed by diphenylalanine peptides
- (2014) Cong Guo et al. Nanoscale
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
- (2014) Jaeyun Kim et al. NATURE BIOTECHNOLOGY
- Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
- (2014) John A Zuris et al. NATURE BIOTECHNOLOGY
- Exploring the sequence space for (tri-)peptide self-assembly to design and discover new hydrogels
- (2014) Pim W. J. M. Frederix et al. Nature Chemistry
- In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors
- (2014) Phil Oh et al. NATURE MEDICINE
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy
- (2014) Ronak Savla et al. PHARMACEUTICAL RESEARCH
- Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering
- (2014) Jia Liu et al. PLoS One
- RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
- (2014) J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
- (2014) J. J. Tao et al. Science Signaling
- A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways
- (2014) S. W. Morton et al. Science Signaling
- Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
- (2014) E. Phillips et al. Science Translational Medicine
- Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literature
- (2014) Paul R. Massey et al. SUPPORTIVE CARE IN CANCER
- Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
- (2014) L. Jeanbart et al. Cancer Immunology Research
- Lipid-Modified Aminoglycoside Derivatives for In Vivo siRNA Delivery
- (2013) Yunlong Zhang et al. ADVANCED MATERIALS
- Vismodegib for the treatment of basal cell skin cancer
- (2013) L. Poggi et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNA
- (2013) Jee Seon Kim et al. BIOMATERIALS
- Nanoparticles containing insoluble drug for cancer therapy
- (2013) Shutao Guo et al. BIOTECHNOLOGY ADVANCES
- Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
- (2013) H. M. Kantarjian et al. BLOOD
- Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
- (2013) Hagop M. Kantarjian et al. CANCER
- Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase I Trial
- (2013) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Concomitant BRAF and PI3K/mTOR Blockade Is Required for Effective Treatment of BRAFV600E Colorectal Cancer
- (2013) E. M. Coffee et al. CLINICAL CANCER RESEARCH
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations
- (2013) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- Polycation liposomes as a vector for potential intracellular delivery of microRNA
- (2013) Hidenori Ando et al. JOURNAL OF GENE MEDICINE
- Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy
- (2013) Xiaoxiao Li et al. MOLECULES
- Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells
- (2013) Haibao Zhu et al. NUCLEIC ACIDS RESEARCH
- Binding, Transcytosis and Biodistribution of Anti-PECAM-1 Iron Oxide Nanoparticles for Brain-Targeted Delivery
- (2013) Mo Dan et al. PLoS One
- Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors
- (2013) Debra H. Josephs et al. THERAPEUTIC DRUG MONITORING
- Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 kinase in KRAS -Mutant Lung Cancer
- (2013) Miriam Molina-Arcas et al. Cancer Discovery
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Probing the Self-Assembly Mechanism of Diphenylalanine-Based Peptide Nanovesicles and Nanotubes
- (2012) Cong Guo et al. ACS Nano
- Acute and Chronic Shear Stress Differently Regulate Endothelial Internalization of Nanocarriers Targeted to Platelet-Endothelial Cell Adhesion Molecule-1
- (2012) Jingyan Han et al. ACS Nano
- Modular ‘Click-in-Emulsion’ Bone-Targeted Nanogels
- (2012) Daniel A. Heller et al. ADVANCED MATERIALS
- Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer
- (2012) Andrew J. Weickhardt et al. CANCER
- Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory
- (2012) Rachael M. Crist et al. Integrative Biology
- Nanoinformatics: a new area of research in nanomedicine
- (2012) Victor Maojo et al. International Journal of Nanomedicine
- Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
- (2012) Isil Altintas et al. JOURNAL OF CONTROLLED RELEASE
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
- (2012) Jeffrey R Infante et al. LANCET ONCOLOGY
- Nilotinib shows prolonged intracellular accumulation upon pulse-exposure: a novel mechanism for induction of apoptosis in CML cells
- (2012) M-C Wagner et al. LEUKEMIA
- Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system
- (2012) Suwussa Bamrungsap et al. Nanomedicine
- Biomolecular coronas provide the biological identity of nanosized materials
- (2012) Marco P. Monopoli et al. Nature Nanotechnology
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurotoxicity of Biologically Targeted Agents in Pediatric Cancer Trials
- (2012) Elizabeth M. Wells et al. PEDIATRIC NEUROLOGY
- Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans
- (2012) Charles Lu et al. PLoS One
- Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
- (2012) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Negative Feedback and Adaptive Resistance to the Targeted Therapy of Cancer
- (2012) Sarat Chandarlapaty Cancer Discovery
- PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
- (2012) Yasir H. Ibrahim et al. Cancer Discovery
- Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer
- (2012) Ashish Juvekar et al. Cancer Discovery
- Porous Quaternized Chitosan Nanoparticles Containing Paclitaxel Nanocrystals Improved Therapeutic Efficacy in Non-Small-Cell Lung Cancer after Oral Administration
- (2011) Pi-Ping Lv et al. BIOMACROMOLECULES
- A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
- (2011) R Plummer et al. BRITISH JOURNAL OF CANCER
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-l-lysine nanocarrier to suppress prostate cancer growth in mice
- (2011) Jianfeng Guo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration
- (2011) Stephanie Hirn et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
- (2011) Rassoul Dinarvand et al. International Journal of Nanomedicine
- Encountering unpredicted off-target effects of pharmacological inhibitors
- (2011) K. Miyazawa JOURNAL OF BIOCHEMISTRY
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanotechnology for therapy and imaging of liver diseases
- (2011) L. Harivardhan Reddy et al. JOURNAL OF HEPATOLOGY
- Atomistic Molecular Dynamics Simulations of Peptide Amphiphile Self-Assembly into Cylindrical Nanofibers
- (2011) One-Sun Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Encapsulation Efficiency and Micellar Structure of Solute-Carrying Block Copolymer Nanoparticles
- (2011) Jeffrey L. Woodhead et al. MACROMOLECULES
- Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles
- (2011) Tomasz Puzyn et al. Nature Nanotechnology
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Cerebrovascular Events After Bevacizumab Treatment: An Early and Severe Complication
- (2011) Raymond C. S. Seet et al. Neurocritical Care
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
- (2011) Claudio Mussolino et al. NUCLEIC ACIDS RESEARCH
- PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
- (2011) V Serra et al. ONCOGENE
- Targeting kidney mesangium by nanoparticles of defined size
- (2011) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors
- (2011) A. Chakrabarty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment
- (2011) R. C. S. Seet et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- Enhancement of DNA uptake in FUT8-deleted CHO cells for transient production of afucosylated antibodies
- (2010) Athena W. Wong et al. BIOTECHNOLOGY AND BIOENGINEERING
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Nanomedicine in pulmonary delivery
- (2010) Heidi Mansour et al. International Journal of Nanomedicine
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Lipid-like materials for low-dose, in vivo gene silencing
- (2010) K. T. Love et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture
- (2009) Megan E. Fox et al. ACCOUNTS OF CHEMICAL RESEARCH
- Subconjunctival Nanoparticle Carboplatin in the Treatment of Murine Retinoblastoma
- (2009) Shin J. Kang ARCHIVES OF OPHTHALMOLOGY
- E-selectin binding peptide–polymer–drug conjugates and their selective cytotoxicity against vascular endothelial cells
- (2009) Yosi Shamay et al. BIOMATERIALS
- Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
- (2009) S Postel-Vinay et al. BRITISH JOURNAL OF CANCER
- Mitotic drivers—inhibitors of the Aurora B Kinase
- (2009) Nicholas Keen et al. CANCER AND METASTASIS REVIEWS
- PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
- (2009) S. Wee et al. CANCER RESEARCH
- Clinical pharmacokinetics of tyrosine kinase inhibitors
- (2009) Nielka P. van Erp et al. CANCER TREATMENT REVIEWS
- Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
- (2009) Teni Boulikas EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets
- (2008) Laure Bachelet et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
- (2008) Z. Liu et al. CANCER RESEARCH
- Nonviral Vectors for Gene Delivery
- (2008) Meredith A. Mintzer et al. CHEMICAL REVIEWS
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
- Delivering drugs by the transdermal route: review and comment
- (2008) T. Tanner et al. SKIN RESEARCH AND TECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now